Cardiac Flow Measurements in Pregnant Women by Non Invasive Techniques

Launched by UNIVERSITY OF GENEVA, SWITZERLAND · Oct 27, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how to measure heart function in pregnant women using new, non-invasive techniques. Researchers want to see how well these new methods, called the Index of Contractility Monitor (ICON) and the Ultra Sonic Cardiac Output Monitor (USCOM), compare to the standard method known as trans-thoracic ultrasound. They are particularly interested in whether the results from these new techniques show a similar heart output measurement, which is the amount of blood the heart pumps, especially during the first and third trimesters of pregnancy. The trial will also look at how comfortable patients feel during the tests, how long the tests take, and how satisfied the examiners are with the process.

To participate in this study, women need to be over 16 years old and receiving prenatal care at the Geneva University Hospitals. However, some individuals may not be eligible, such as those with a history of drug or alcohol abuse, certain heart conditions, or those unable to provide informed consent. If you join the study, you can expect to undergo three different heart function tests and share your experiences regarding comfort and satisfaction with each method. This research aims to improve how we monitor heart health in pregnant women, ensuring both safety and comfort during these important assessments.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Any pregnant person over 16 years old followed at the prenatal consultation of the maternity ward of the Geneva University Hospitals.
• Exclusion Criteria:
• • Drug or alcohol abuse,
• • Miscarriage or intra uterine demise before the first exam.
• • Inability to follow the procedures of the investigation, e.g. due to psychological disorders, dementia, etc. of the subject,
• • Inability to give an informed consent.
• • preexisting or congenital cardiopathy
• • Structural abnormalities of hearth or valves diagnosed in the first Trans Thoracic Echocardiography screening